![](https://pharma.industry-report.net/wp-content/uploads/2019/03/usfda-326x245.png)
Strides receives USFDA approval for Ethosuximide Softgel capsules
Strides Pharma Science through its subsidiary has received USFDA approval for Ethosuximide Softgel capsules prescribed as an anti-epileptic medication. The drug is a generic version […]